United Laboratories repurchases 0.50 million shares for HKD 4.11 million; issued share capital steady at 1.97 billion

Bulletin Express06-23

The United Laboratories International Holdings Limited (United Laboratories) reported that it bought back 500,000 ordinary shares on 23 June 2026 through on-market transactions at prices ranging from HKD 8.13 to HKD 8.32 per share, for a total consideration of HKD 4.11 million. The volume-weighted average purchase price was approximately HKD 8.23 per share. All repurchased shares are earmarked for cancellation.

Including this latest tranche, United Laboratories has repurchased 2.75 million shares between 16 June and 23 June 2026 at an average cost of about HKD 8.23 per share, representing roughly 0.14% of the company’s 1.97 billion issued shares. Aggregate cash deployed across the five trading sessions amounts to approximately HKD 22.63 million.

Despite the buybacks, the company’s issued share capital remains unchanged at 1.97 billion shares pending formal cancellation of the repurchased stock. The current repurchases utilise 0.25% of the 197.30 million-share mandate granted by shareholders on 23 June 2026.

In accordance with Hong Kong Stock Exchange rules, United Laboratories is subject to a moratorium on issuing new shares or selling treasury shares until 23 July 2026. The board confirms that all repurchase activities complied with Main Board requirements and the terms of the previously published explanatory statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1141105836?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141105836","market":"us","top_or_hot":-1,"title":"United Laboratories repurchases 0.50 million shares for HKD 4.11 million; issued share capital steady at 1.97 billion","media":"Bulletin Express","content":"<p>The United Laboratories International Holdings Limited (United Laboratories) reported that it bought back 500,000 ordinary shares on 23 June 2026 through on-market transactions at prices ranging from HKD 8.13 to HKD 8.32 per share, for a total consideration of HKD 4.11 million. The volume-weighted average purchase price was approximately HKD 8.23 per share. All repurchased shares are earmarked for cancellation.</p>\n<p>Including this latest tranche, United Laboratories has repurchased 2.75 million shares between 16 June and 23 June 2026 at an average cost of about HKD 8.23 per share, representing roughly 0.14% of the company’s 1.97 billion issued shares. Aggregate cash deployed across the five trading sessions amounts to approximately HKD 22.63 million.</p>\n<p>Despite the buybacks, the company’s issued share capital remains unchanged at 1.97 billion shares pending formal cancellation of the repurchased stock. The current repurchases utilise 0.25% of the 197.30 million-share mandate granted by shareholders on 23 June 2026.</p>\n<p>In accordance with Hong Kong Stock Exchange rules, United Laboratories is subject to a moratorium on issuing new shares or selling treasury shares until 23 July 2026. The board confirms that all repurchase activities complied with Main Board requirements and the terms of the previously published explanatory statement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>United Laboratories repurchases 0.50 million shares for HKD 4.11 million; issued share capital steady at 1.97 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnited Laboratories repurchases 0.50 million shares for HKD 4.11 million; issued share capital steady at 1.97 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-23 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The United Laboratories International Holdings Limited (United Laboratories) reported that it bought back 500,000 ordinary shares on 23 June 2026 through on-market transactions at prices ranging from HKD 8.13 to HKD 8.32 per share, for a total consideration of HKD 4.11 million. The volume-weighted average purchase price was approximately HKD 8.23 per share. All repurchased shares are earmarked for cancellation.</p>\n<p>Including this latest tranche, United Laboratories has repurchased 2.75 million shares between 16 June and 23 June 2026 at an average cost of about HKD 8.23 per share, representing roughly 0.14% of the company’s 1.97 billion issued shares. Aggregate cash deployed across the five trading sessions amounts to approximately HKD 22.63 million.</p>\n<p>Despite the buybacks, the company’s issued share capital remains unchanged at 1.97 billion shares pending formal cancellation of the repurchased stock. The current repurchases utilise 0.25% of the 197.30 million-share mandate granted by shareholders on 23 June 2026.</p>\n<p>In accordance with Hong Kong Stock Exchange rules, United Laboratories is subject to a moratorium on issuing new shares or selling treasury shares until 23 July 2026. The board confirms that all repurchase activities complied with Main Board requirements and the terms of the previously published explanatory statement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03933","symbol_name":"联邦制药","start_time":0,"source_url":"","article_id":"1141105836","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141105836","pubTimestamp":1782225890,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"The United Laboratories International Holdings Limited (United Laboratories) reported that it bought back 500,000 ordinary shares on 23 June 2026 through on-market transactions at prices ranging from...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03933":"联邦制药"},"translate_title":"联邦制药411万港元回购0.50万股；已发行股本稳定在19.7亿","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":1},"content_text":"The United Laboratories International Holdings Limited (United Laboratories) reported that it bought back 500,000 ordinary shares on 23 June 2026 through on-market transactions at prices ranging from HKD 8.13 to HKD 8.32 per share, for a total consideration of HKD 4.11 million. The volume-weighted average purchase price was approximately HKD 8.23 per share. All repurchased shares are earmarked for cancellation.\nIncluding this latest tranche, United Laboratories has repurchased 2.75 million shares between 16 June and 23 June 2026 at an average cost of about HKD 8.23 per share, representing roughly 0.14% of the company’s 1.97 billion issued shares. Aggregate cash deployed across the five trading sessions amounts to approximately HKD 22.63 million.\nDespite the buybacks, the company’s issued share capital remains unchanged at 1.97 billion shares pending formal cancellation of the repurchased stock. The current repurchases utilise 0.25% of the 197.30 million-share mandate granted by shareholders on 23 June 2026.\nIn accordance with Hong Kong Stock Exchange rules, United Laboratories is subject to a moratorium on issuing new shares or selling treasury shares until 23 July 2026. The board confirms that all repurchase activities complied with Main Board requirements and the terms of the previously published explanatory statement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141105836","isCrawlerRequest":true}